Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite
Marine Drugs · 2025
DOI: 10.3390/md23090349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Anna Kaczmarek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Łukasiewicz Research Network-Lodz Institute of Technology, 19/27 Marii Sklodowskiej-Curie Str., 90-570 Lodz, Poland. Hauptthemen laut MEDLINE: Alginates, Zinc Compounds, Polyesters, Sulfides. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre (Poland).
Abstract (Originalsprache)
The aim of this study was to evaluate the haemostatic potential and biocompatibility of a newly developed composite material for its use in blood-contacting applications. Based on promising reports on polylactide (PLA), sodium alginate (ALG), and bioactive additives such as hardystonite (HT) and zinc sulphide (ZnS), a melt-blown PLA nonwoven was modified via dip-coating using an ALG solution as a matrix for incorporating HT and ZnS particles, resulting in the PLA-ALG-ZnS-HT composite. The material was characterised in terms of surface morphology, specific surface area, pore volume, average pore size, and zeta potential (pH~7.4). Haemostatic activity was assessed by measuring blood coagulation parameters, while biocompatibility was evaluated through the viability of human peripheral blood mononuclear (PBM) cells and human foreskin fibroblasts (Hs68). Genotoxicity was analysed using the comet assay and plasmid relaxation test. Results confirmed a uniform alginate coating with dispersed HT and ZnS particles on PLA fibres. The modification increased the surface area and pore volume and caused a shift toward less negative zeta potential. Haemostatic testing showed prolonged activated partial thromboplastin time (aPTT), likely due to Zn2+ interactions with clotting factors. Biocompatibility tests showed high cell viability and no genotoxic effects. Our findings suggest that the PLA-ALG-ZnS-HT composite is safe for blood and skin cells and may serve as an anticoagulant material.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Łukasiewicz Research Network-Lodz Institute of Technology, 19/27 Marii Sklodowskiej-Curie Str., 90-570 Lodz, Poland.
- Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.
ORCID-Profile: Anna Kaczmarek, Jerzy J Chruściel, Katarzyna Woźniak, Marcin H Kudzin
Förderung
- National Science Centre (Poland)
Zitieren
APA
Kaczmarek, A., Mrozińska, Z., Chruściel, J. J., Juszczak, M., Woźniak, K., & Kudzin, M. H. (2025). Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite. Marine Drugs. https://doi.org/10.3390/md23090349
Vancouver
Kaczmarek A, Mrozińska Z, Chruściel JJ, Juszczak M, Woźniak K, Kudzin MH. Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite. Marine Drugs. 2025. doi:10.3390/md23090349
BibTeX
@article{Kaczmarek2025,
author = {Kaczmarek, Anna and Mrozińska, Zdzisława and Chruściel, Jerzy J and Juszczak, Michał and Woźniak, Katarzyna and Kudzin, Marcin H},
title = {Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23090349}
}
EUVIMED